| Dr Lisa Kim Ellman-grunther, MD | |
|
115 Broadway, Ste 1800, New York, NY 10006-1652 | |
| (646) 854-2003 | |
| (646) 493-7299 |
| Full Name | Dr Lisa Kim Ellman-grunther |
|---|---|
| Gender | Female |
| Speciality | Allergy/immunology |
| Experience | 28 Years |
| Location | 115 Broadway, New York, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336107325 | NPI | - | NPPES |
| 8970700 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207KA0200X | Allergy & Immunology - Allergy | 25MMAO7471600 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lisa Kim Ellman-grunther, MD Po Box 11205, Fairfield, NJ 07004-7205 Ph: (646) 854-2003 | Dr Lisa Kim Ellman-grunther, MD 115 Broadway, Ste 1800, New York, NY 10006-1652 Ph: (646) 854-2003 |
News Archive
Provepharm, a start-up specialized in the development of pharmaceutical applications, announces today that, following a one-year centralized review procedure, the European Medicines Agency's Committee for Medicinal Products for Human Use (CMPH) issued a favorable assessment of its methylthioninium chloride Proveblue on 17 February.
The ACE Group today announced the release of an environmental advisory entitled, "Legionella and Mold: Construction and Renovation Risks at Healthcare Facilities," which explores the potential risks of pollutants, such as mold and legionella, that hospitals and healthcare facilities can experience during renovation or construction projects.
Echo Therapeutics, Inc., a company developing its needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude™ SkinPrep System for transdermal drug delivery, today announced that it is beginning a development program designed to create a new transdermal biosensor for continuous lactate monitoring to be used in critical care and sports medicine.
As the panel's Nov. 23 deadline approaches and doubts about its ability for success persist, a new approach is emerging in which the panel may opt to postpone politically difficult decisions by deciding the amount of new revenue their deficit-reduction plan would require, but leaving specifics to Congress' tax-writing committees to fill in next year.
Compared with those on placebos, giving heparin to people who have heart conditions like unstable angina and some forms of heart attack reduces the risk of having another heart attack, concluded a Cochrane Systematic Review.
› Verified 9 days ago
Dr. Joanne Moreau, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 414 E 75th St Fl 3, New York, NY 10021 Phone: 212-548-7124 | |
Dr. Monica Gupta, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 550 1st Ave, Nbv 16n30, Internal Medicine Residency Program, New York, NY 10016 Phone: 212-263-6397 | |
Mary S. Bayno, D.O. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 119 West 57th Street, Suite 1520, New York, NY 10019 Phone: 212-765-6474 Fax: 212-245-3536 | |
Deborah Weichenberg, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 2121 Broadway, Ste 401a, New York, NY 10023 Phone: 212-769-3535 Fax: 212-496-1665 | |
Gozen Tuysuzoglu, MD Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 506 Lenox Ave, New York, NY 10037 Phone: 201-835-8902 Fax: 212-939-8013 | |
Dr. Edith Schussler, MD Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 1440 York Ave Ofc P10, New York, NY 10075 Phone: 646-470-5747 Fax: 646-777-1794 | |
Dr. Bruce S Dobozin, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 2 Peter Cooper Rd, Suite 10e, New York, NY 10010 Phone: 212-602-1353 Fax: 212-602-1353 |